Pharma

All articles by Pharma

Five things for pharma marketers to know: Thursday, August 11, 2022
Five things for pharma marketers to know: Thursday, August 11, 2022
Mackenzie Allen
August 11, 2022
5:00 am

Court finds Walgreens liable for opioids in San Francisco; London children to be offered a polio booster; FDA will allow children to be vaccinated for monkeypox.

Endo, under siege from opioid lawsuits, says bankruptcy filing ‘imminent’
Endo, under siege from opioid lawsuits, says bankruptcy filing ‘imminent’
Marc Iskowitz
August 10, 2022
1:33 pm

The drugmaker does not have an agreement in place to deal with the vast majority of opioid lawsuits it is facing.

Five things for pharma marketers to know: Wednesday, August 10, 2022
Five things for pharma marketers to know: Wednesday, August 10, 2022
Mackenzie Allen
August 10, 2022
5:00 am

Senate to vote again on insulin price cap; Texas challenges coverage for preventive care; FDA okays intradermal injection of monkeypox vax.

More ‘games’ in store? Drugmakers ponder response to Medicare price controls
More ‘games’ in store? Drugmakers ponder response to Medicare price controls
Marc Iskowitz
August 9, 2022
4:06 pm

Potential countermeasures could range from higher launch prices to authorized generics.

Five things for pharma marketers to know: Tuesday, August 9, 2022
Five things for pharma marketers to know: Tuesday, August 9, 2022
Mackenzie Allen
August 9, 2022
5:00 am

BioNTech to deliver Omicron-adapted vaccine in October; Women self-managing abortions in Roe’s wake; GOP Senators block insulin cost cap.

M&A season continues with Pfizer’s $5.4B acquisition of GBT
M&A season continues with Pfizer’s $5.4B acquisition of GBT
Marc Iskowitz
August 8, 2022
3:01 pm

The deal gives Pfizer access to GBT’s sickle-cell drug Oxbryta and late-stage pipeline.

Earnings season week 3: BioNTech revenues, net profit drop
Earnings season week 3: BioNTech revenues, net profit drop
Jack O'Brien
August 8, 2022
10:46 am

Despite the financial dropoff, BioNTech reiterated its outlook for 2022.

Five things for pharma marketers to know: Monday, August 8, 2022
Five things for pharma marketers to know: Monday, August 8, 2022
Mackenzie Allen
August 8, 2022
5:00 am

U.S. declares monkeypox a public health emergency; Spain reports hepatitis deaths in children; Polio found in New York wastewater samples.

Five things for pharma marketers to know: Friday, August 5, 2022
Five things for pharma marketers to know: Friday, August 5, 2022
Mackenzie Allen
August 5, 2022
5:00 am

CDC to ease COVID restrictions for schools; Senate bill introduced to help people with disabilities access reproductive health care; monkeypox cases multiply in India.

More earnings: Amgen announces results and acquisition, Vertex product revenue hits $2.2B
More earnings: Amgen announces results and acquisition, Vertex product revenue hits $2.2B
Jack O'Brien
August 4, 2022
4:43 pm

Amgen will purchase ChemoCentryx, which focuses on orally administered treatments for autoimmune diseases, inflammatory disorders and cancer, for $3.7 billion.

  • From Our Partners